Friday, September 20, 2024
HomeTagsEuclidean Capital

Euclidean Capital

A2 Bio to Present at ASCO-GI 2022 to Identify GI Cancer Patients for Future Tmod™ CAR T Therapy

A2 Biotherapeutics, Inc. ("A2 Bio") is a biotechnology company focused on the development of a first-in-class, logic-gated Tmod™ CAR T cell therapy platform to...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics